Migden, M., Schmults, C., Khushalani, N., Guminski, A. ., Chang, A. L., Lewis, K. ., Ansstas, G. ., Bowyer, S. ., Hughes, B. ., Schadendorf, D. ., Modi, B. ., Dunn, L. ., Flatz, L. ., Hauschild, A. ., Yoo, S.-Y. ., Booth, J. ., Seebach, F. ., Lowy, I. ., Fury, M. ., & Rischin, D. . (2023). Phase 2 study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 Groups 1, 2, and 3. SKIN The Journal of Cutaneous Medicine, 7(2), s176. https://doi.org/10.25251/skin.7.supp.176